Navigation Links
A turn-off for cancer
Date:6/7/2010

Although plants and animals are very different organisms, they share a surprising number of biological mechanisms. A plant biologist at Tel Aviv University says that one of these mechanisms may be the answer for turning off cancer growth in humans.

Prof. Shaul Yalovsky, of the Molecular Biology and Ecology of Plants Department at Tel Aviv University, has identified a "switch" that can turn on cell growth in plants. Now, in a laboratory setting, he can apply the mechanism to reshape cells, grow new tissues, and respond to bacterial or viral invaders.

The switch is actually a fat molecule that modulates a group of proteins called ROPs. Reported in the scientific journal Current Biology, Prof. Yalovsky's research group, in collaboration with Prof. Yoav Henis and Dr. Joel Hirsch of TAU's Departments of Neurobiology and Biochemistry, has determined that this fat molecule is required for ROP activity. Proteins very similar to ROPs exist in humans and provide chemical signals that tell cancer when to metastasize. Now that they know how to regulate ROPs in plants, the researchers believe they are one step away from turning this ROP-like switch off in humans a process which could prevent tumor growth.

An ancient secret revealed

"We've stumbled upon an ancient mechanism that regulates the function of these proteins, proteins which are found in both plants and humans," says Prof. Yalovsky, explaining that this mechanism already regulates the immune response to pathogen invaders in the human body. ROP-like proteins are also involved in wound healing and development of nerve cells in the brain.

"When these proteins are turned 'on,' they can initiate processes like cell division and growth," says Prof. Yalovsky. "Through our genetic engineering, these proteins could be manipulated in humans to speed up tissue healing, or turned off to slow or stop the growth of tumors."

ROPs bind to a small molecule called GTP, which then breaks up into another molecule called GDP. When bound to GDP, ROPs become inactive, a known concept in the plant sciences community. Going one step further, Prof. Yalovsky has created a second type of mutant molecule that prevents ROP proteins from binding to the GTP molecule, creating an inhibitory effect.

A new line of defense

The team's research could also be applied in agriculture to reduce the need for chemical pesticides, they say. The mutant molecule they've devised induces plants to respond as though they are being attacked by pathogens. They then create a biological defense that protects them from infection.

In the research paper, the Tel Aviv University scientists describe how these mutations and mechanisms work, providing a new mechanism to control metastasis in cancer, or stop the deterioration of certain nerve cells in the brain. And in a broader sense, the researchers have created a long-desired platform to test the function of proteins.

"It is common for plant and animal geneticists to identify proteins, but remain unaware of their functions. We now have a mechanism to test our hypotheses," adds Prof. Yalovsky.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related medicine news :

1. Non-melanoma skin cancer may help identify survivors at increased risk for future cancers
2. Consortium seeks best treatment for HIV-positive cancer patients
3. Drug that helps metastatic colon cancer of no benefit in less advanced tumors
4. B2Discovery: Entrepreneurs and researchers join forces to conquer cancer
5. ASCO data show serum DNA blood tests detect cancers with high sensitivity and specificity
6. Molecular imaging detects recurrent prostate cancer
7. New treatment regimen shown effective against advanced ovarian cancer
8. Targeted Therapy Shows Promise Against Deadly Brain Cancer
9. Less-invasive Lymph Node Resection Following Breast Cancer Surgery Confirmed as Standard of Care in Eight-year Study Led by AGH Doctors
10. Researchers Report Treatment Headway Against Lung Cancer
11. Selenium shows no benefit in prevention of lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A turn-off for cancer
(Date:8/17/2017)... ... August 17, 2017 , ... Inc. Magazine Unveils 36th Annual List of ... Three-Year Sales Growth of 3,004.8% , NEW YORK, August 16, 2017 – Inc. magazine ... prestigious ranking of the nation's fastest-growing private companies. The list represents a unique look ...
(Date:8/17/2017)... ... , ... Momkus McCluskey Roberts LLC recently announced it was naming ... the firm’s Commercial Litigation and Employment Law groups. , Ms. Parks joined Momkus ... of employment litigation, commercial litigation and business disputes. Her experience includes all aspects of ...
(Date:8/17/2017)... Yorba Linda, Ca (PRWEB) , ... August 17, 2017 , ... ... centrifuges are useful tools in the laboratory that we can no longer do without. ... to prolong the lifetime of your device. , In this webinar, attendees will learn ...
(Date:8/17/2017)... ... , ... A recent report indicates that circa 79 percent of 483 warning ... data integrity. The FDA outlines their expectations for quality critical instrumentation in the GMP ... the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, this webinar ...
(Date:8/16/2017)... ... August 16, 2017 , ... Summer days spent with family are priceless. ... put together suggestions for enjoying the season of sunshine. Add trying something new to ... family can join in on the fun. , Try Something New ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)... Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, Belmar ... The reputable clinic will continue to be co-owned and managed ... of four clinicians. Lipkin received his doctorate in physical therapy ... of experience with a strong background in manual therapy. ... clinic in and around the Denver ...
(Date:8/7/2017)... WARSAW, Ind. , Aug. 7, 2017 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the third quarter of 2017. ... will be paid on or about October 27, 2017 to ... September 22, 2017.  Future declarations of dividends are subject to ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
Breaking Medicine Technology: